Citation: | WANG Hongbing, WANG Manxiang, WAN Li, CAI Weina, CHEN Jinbo, PI Guoliang. Interpretation of Expert Consensus on Diagnosis and Treatment of Cutaneous Basal Cell Carcinoma (2021) by A Multidisciplinary Team[J]. Cancer Research on Prevention and Treatment, 2023, 50(4): 427-432. DOI: 10.3971/j.issn.1000-8578.2023.22.1287 |
Basal cell carcinoma (BCC) is the most common malignant tumor in dermatology with incidence rising rapidly. Expert consensus on diagnosis and treatment of cutaneous basal cell carcinoma (2021) was published in September 2021 by Skin Tumor Research Center, Chinese Society of Dermatology and Subcommittee on Skin Tumor, China Dermatologist Association. This consensus comprehensively describes the epidemiology, pathogenesis, clinical manifestations, auxiliary examination, pathology, pretreatment assessment, treatment, prognosis, and follow-up education. It offers an important guideline for promoting the standardized diagnosis and treatment of skin BCC in China. In this work, multidisciplinary experts interpreted the main contents of the consensus, including clinicopathological findings, pretreatment assessment, and treatment advance.
[1] |
中华医学会皮肤性病学分会皮肤肿瘤研究中心, 中国医师协会皮肤科医师分会皮肤肿瘤学组. 皮肤基底细胞癌诊疗专家共识(2021)[J]. 中华皮肤科杂志, 2021, 54(9): 757-764.
Skin Tumor Research Center, Chinese Society of Dermatology, Subcommittee on Skin Tumor, China Dermatologist Association. Expert Consensus on Diagnosis and Treatment of Skin Basal Cell Carcinoma (2021)[J]. Zhonghua Pi Fu Ke Za Zhi, 2021, 54(9): 757-764.
|
[2] |
Goon PKC, Greenberg DC, Igali L, et al. Predicted cases of U.K. skin squamous cell carcinoma and basal cell carcinoma in 2020 and 2025: horizon planning for National Health Service dermatology and dermatopathology[J]. Br J Dermatol, 2017, 176(5): 1351-1353. doi: 10.1111/bjd.15110
|
[3] |
Peris K, Fargnoli MC, Garbe C, et al. Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines[J]. Eur J Cancer, 2019, 118: 10-34. doi: 10.1016/j.ejca.2019.06.003
|
[4] |
Nasr I, McGrath EJ, Harwood CA, et al. British Association of Dermatologists guidelines for the management of adults with basal cell carcinoma 2021[J]. Br J Dermatol, 2021, 185(5): 899-920. doi: 10.1111/bjd.20524
|
[5] |
Solimani F, Juratli H, Hoch M, et al. Basal cell carcinoma of the scrotum: an important but easily overlooked entity[J]. J Eur Acad Dermatol Venereol, 2018, 32(6): e254-e255. doi: 10.1111/jdv.14823
|
[6] |
Cohen PR. Basal cell carcinoma: Additional subtypes and therapeutic advances[J]. J Am Acad Dermatol, 2019, 81(1): e17. doi: 10.1016/j.jaad.2019.02.046
|
[7] |
中国中西医结合学会皮肤性病专业委员会皮肤影像学组, 中国医疗保健国际交流促进会皮肤科分会皮肤影像学组, 中华医学会皮肤性病学分会皮肤病数字化诊断亚学组, 等. 中国基底细胞癌皮肤镜特征专家共识(2019)[J]. 中华皮肤科杂志, 2019(6): 371-377. doi: 10.3760/cma.j.issn.0412-4030.2019.06.001
Skin Imaging Group, Committee on Dermatology and Venereology, Chinese Association of Integrative Medicine, Skin Imaging Group, Dermatology Branch of China International Exchange and Promotion Association for Medical and Healthcare, Subgroup of Digital Diagnosis of Skin Diseases, Chinese Society of Dermatology, et al. Dermoscopic characteristics of basal cell carcinoma: a Chinese expert consensus statement (2019)[J]. Zhonghua Pi Fu Ke Za Zhi, 2019(6): 371-377. doi: 10.3760/cma.j.issn.0412-4030.2019.06.001
|
[8] |
Sinx KAE, van Loo E, Tonk EHJ, et al. Optical Coherence Tomography for Noninvasive Diagnosis and Subtyping of Basal Cell Carcinoma: A Prospective Cohort Study[J]. J Invest Dermatol, 2020, 140(10): 1962-1967. doi: 10.1016/j.jid.2020.01.034
|
[9] |
Monnier J, De Carvalho N, Harris U, et al. Combined reflectance confocal microscopy and optical coherence tomography to improve the diagnosis of equivocal lesions for basal cell carcinoma[J]. J Am Acad Dermatol, 2022, 86(4): 934-936. doi: 10.1016/j.jaad.2021.03.066
|
[10] |
Gill M, Sahu A, Alessi-Fox C, et al. Angulated small nests and cords: Key diagnostic histopathologic features of infiltrative basal cell carcinoma can be identified using integrated reflectance confocal microscopy-optical coherence tomography[J]. J Cutan Pathol, 2021, 48(1): 53-65. doi: 10.1111/cup.13871
|
[11] |
Navarrete-Dechent C, Cordova M, Aleissa S, et al. Reflectance confocal microscopy confirms residual basal cell carcinoma on clinically negative biopsy sites before Mohs micrographic surgery: A prospective study[J]. J Am Acad Dermatol, 2019, 81(2): 417-426. doi: 10.1016/j.jaad.2019.02.049
|
[12] |
Campanella G, Navarrete-Dechent C, Liopyris K, et al. Deep Learning for Basal Cell Carcinoma Detection for Reflectance Confocal Microscopy[J]. J Invest Dermatol, 2021, 142(1): 97-103.
|
[13] |
中华医学会皮肤性病学分会皮肤肿瘤研究中心, 中国医师协会皮肤科医师分会皮肤肿瘤学组. 皮肤鳞状细胞癌规范化诊疗共识(2021)[J]. 中华皮肤科杂志, 2021, 54(8): 653-664.
Skin Tumor Research Center of Dermatology and Venereology Branch of Chinese Medical Association, Skin Cancer Group of Dermatology and Dermatology Branch of Chinese Medical Association. Consensus on Standardized Diagnosis and Treatment of Skin Squamous Cell Carcinoma (2021)[J]. Zhonghua Pi Fu Ke Za Zhi, 2021, 54(8): 653-664.
|
[14] |
Lemos MB, Okoye E. Atlas of Surgical Pathology Grossing: Atlas of Anatomic Pathology[M]. Publisher: Springer Cham, 2019: 1-4.
|
[15] |
Elder DE, Massi D, Scolyer RA, et al. World Health Organization Classification of Skin Tumours (4th edition)[M]. Lyon: IARC, 2018: 26-34.
|
[16] |
Gompertz-Mattar M, Perales J, Sahu A, et al. Differential expression of programmed cell death ligand 1 (PD-L1) and inflammatory cells in basal cell carcinoma subtypes[J]. Arch Dermatol Res, 2022, 314(8): 777-786.
|
[17] |
National Comprehensive Cancer Network. Basal cell skincancer, version 2. 2021, NCCN clinical practice guidelines inoncology[Z/OL]. (2021-02-25)[2021- 07-01]. https://www.nccn.org/professionals/physician_gls/pdf/nmsc.pdf.
|
[18] |
中华医学会皮肤性病学分会光动力治疗研究中心. 氨基酮戊酸光动力疗法皮肤科临床应用指南(2021版)[J]. 中华皮肤科杂志, 2021, 54(1): 1-9.
Photodynamic Therapy Research Center of Dermatology and Venereal Disease Branch of Chinese Medical Association. Clinical Application Guide of Aminolevulinic Acid Photodynamic Therapy Dermatology (2021 Edition)[J]. Zhonghua Pi Fu Ke Za Zhi, 2021, 54(1): 1-9.
|
[19] |
Work Group, Invited Reviewers, Kim JYS, et al. Guidelines of care for the management of basal cell carcinoma[J]. J Am Acad Dermatol, 2018, 78(3): 540-559. doi: 10.1016/j.jaad.2017.10.006
|
[20] |
Peris K, Fargnoli MC, Garbe C, et al. Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines[J]. Eur J Cancer, 2019, 118: 10-34. doi: 10.1016/j.ejca.2019.06.003
|
[21] |
Weissman JP, Samlowski W, Meoz R. Hedgehog Inhibitor Induction with Addition of Concurrent Superficial Radiotherapy in Patients with Locally Advanced Basal Cell Carcinoma: A Case Series[J]. Oncologist, 2021, 26(12): e2247-e2253. doi: 10.1002/onco.13959
|
[22] |
Drucker AM, Adam GP, Rofeberg V, et al. Treatments of Primary Basal Cell Carcinoma of the Skin: A Systematic Review and Network Meta-analysis[J]. Ann Intern Med, 2018, 169(7): 456-466. doi: 10.7326/M18-0678
|
[23] |
Soon SL, Ibrahim SF, Arron ST. A randomized phaseⅡ study evaluating vismodegib as neoadjuvant treatment of basal cell carcinoma preceding Mohs micrographic surgery: results and lessons learned[J]. Br J Dermatol, 2019, 181(1): 208-209. doi: 10.1111/bjd.17623
|
[24] |
van Winden MEC, Hetterschijt CRM, Bronkhorst EM, et al. Evaluation of Watchful Waiting and Tumor Behavior in Patients With Basal Cell Carcinoma: An Observational Cohort Study of 280 Basal Cell Carcinomas in 89 Patients[J]. JAMA Dermatol, 2021, 157(10): 1174-1181.
|
Tables(2)